Breaking News

Charles River Completes NewLab Acquisition

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Laboratories has completed the acquisition of privately held NewLab BioQuality AG, a Dusseldorf, Germany-based provider of safety and quality control services to biopharmaceutical clients. NewLab joins Charles River Biopharmaceutical Services, which provides services to support the development and manufacture of biologics.     James C. Foster, chairman, president and chief executive officer of Charles River, said, “The acquisition of NewLab further strengthens our portfoli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters